Intrapartum Monitoring Devices Market Report 2024: Analysis and Growth

The Business Research Company recently released a comprehensive report on the Global Intrapartum Monitoring Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

According to The Business Research Company's, the intrapartum monitoring devices market size has grown strongly in recent years. It will grow from $2.04 billion in 2023 to $2.18 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to technological advancements, increasing maternal age, rising prevalence of preterm births, government initiatives, and funding, and growing awareness and education

The intrapartum monitoring devices market size is expected to see strong growth in the next few years. It will grow to $2.85 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to the rising incidence of pregnancy complications, growing awareness and education, government initiatives and policies, increasing healthcare expenditure, increasing healthcare expenditure, and the aging maternal population. Major trends in the forecast period include wireless monitoring devices, telehealth integration, rising prevalence of high-risk pregnancies, improved accuracy and reliability, and regulatory approvals and guidelines.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/intrapartum-monitoring-devices-global-market-report

Market Drivers and Trends:

The rising prevalence of gynecological diabetes is expected to propel the growth of the intrapartum monitoring device market going forward. Gynecological diabetes, also known as gestational diabetes mellitus (GDM), is a condition characterized by high blood sugar (glucose) levels that develop during pregnancy and typically resolve after giving birth. The prevalence of gynecological diabetes is growing due to increasing rates of obesity and sedentary lifestyles. Intrapartum monitoring devices are used in gynecological diabetes to continuously monitor the fetal heart rate and uterine contractions, ensuring the timely detection and management of potential complications during labor and delivery. For instance, in 2022, the International Diabetes Federation, a Belgium-based diabetes organization, reported that in 2021, approximately 21.1 million live births, or 16.7%, experienced some form of high blood glucose (hyperglycemia) during pregnancy. This condition is more prevalent in low- and middle-income countries with limited access to maternal care. Women over 45, as well as those with a history of gestational diabetes mellitus (GDM), are at higher risk of hyperglycemia during pregnancy and face an increased likelihood of developing type 2 diabetes within five to ten years after delivery. Therefore, the rising prevalence of gynecological diabetes is driving the growth of the intrapartum monitoring device market.

Major companies operating in the intrapartum monitoring device market are increasing their focus on developing innovative products such as wireless and belt-free designs to sustain their position in the market. Wireless and belt-free designs in intrapartum monitoring devices allow for unobstructed movement and increased comfort for the mother while ensuring continuous monitoring of fetal heart rate and uterine contractions. For instance, in February 2024, GE HealthCare Technologies Inc., a US-based medical technology company, obtained clearance for its Novii+ Wireless Maternal and Fetal Monitoring Solution. This clearance allows the device to monitor approximately 95% of all eligible births in the United States. The Novii+ system is designed for pregnant patients at or beyond 34 weeks and offers noninvasive monitoring of fetal heart rate, maternal heart rate, and uterine activity. It features a wireless and belt-free design, enhancing mobility and potentially improving the comfort and experience of expectant mothers during labor. The device incorporates an advanced algorithm called cross-check artifact reduction, which improves the accuracy and reliability of the collected data. 

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=18649&type=smp

Major Key Players of the Market:

Cardinal Health Inc; Medtronic PLC; Fujifilm Holdings Corporation; Philips Healthcare; GE HealthCare Technologies Inc.; Shenzhen Mindray Bio-Medical Electronics Co. Ltd; Drägerwerk AG & Co. KGaA; CooperSurgical Inc.; Spacelabs Healthcare; Nihon Kohden Corporation; Contec Medical Systems Co Ltd.; Mediana Co Ltd.; Natus Medical Incorporated; EDAN Instruments Inc.; Guangdong Biolight Meditech Co. Ltd; Dixion Vertrieb medizinischer Geräte GmbH; Bionet America Inc.; Shenzhen Bestman Instrument Co Ltd.; Huntleigh Healthcare Limited; Neoventa Medical AB; Trismed Co Ltd.

Intrapartum Monitoring Devices Market 2024 Key Insights:

• The intrapartum monitoring devices market size is expected to grow to $2.85 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%.
• Rising Prevalence Of Gynecological Diabetes Drives Growth In Intrapartum Monitoring Device Market
• Innovative Wireless And Belt-Free Intrapartum Monitoring Devices
• North America was the largest region in the intrapartum monitoring devices market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/customise?id=18649&type=smp

Contact Us:

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.